- Home
- INV vs QSI Comparison
INV vs QSI Comparison
Compare INV & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INV
- QSI
- Stock Information
- Founded
- INV 2015
- QSI 2013
- Country
- INV United States
- QSI United States
- Employees
- INV N/A
- QSI N/A
- Industry
- INV
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- INV
- QSI Health Care
- Exchange
- INV NYSE
- QSI Nasdaq
- Market Cap
- INV 662.9M
- QSI 633.2M
- IPO Year
- INV N/A
- QSI N/A
- Fundamental
- Price
- INV $12.37
- QSI $2.44
- Analyst Decision
- INV
- QSI Buy
- Analyst Count
- INV 0
- QSI 2
- Target Price
- INV N/A
- QSI $3.25
- AVG Volume (30 Days)
- INV 131.2K
- QSI 59.3M
- Earning Date
- INV 02-15-2025
- QSI 02-27-2025
- Dividend Yield
- INV N/A
- QSI N/A
- EPS Growth
- INV N/A
- QSI N/A
- EPS
- INV N/A
- QSI N/A
- Revenue
- INV $988,000.00
- QSI $2,266,000.00
- Revenue This Year
- INV N/A
- QSI $193.90
- Revenue Next Year
- INV N/A
- QSI $173.18
- P/E Ratio
- INV N/A
- QSI N/A
- Revenue Growth
- INV 4.88
- QSI 232.26
- 52 Week Low
- INV $8.55
- QSI $0.61
- 52 Week High
- INV $18.75
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- INV N/A
- QSI 51.15
- Support Level
- INV N/A
- QSI $2.20
- Resistance Level
- INV N/A
- QSI $2.68
- Average True Range (ATR)
- INV 0.00
- QSI 0.75
- MACD
- INV 0.00
- QSI -0.14
- Stochastic Oscillator
- INV 0.00
- QSI 15.05
About INV INNVENTURE INC
Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.